Page not found

Search results

  1. Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

    ... announced an agreement with  Illumina , a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, ... next step, allowing us to utilize their global presence and technology to join with industry partners, realizing our vision to achieve the ...

    sommers - 01/11/2022 - 11:06am

  2. Small Molecule-GIRK Potassium Channel Modulators That Are Anxiolytic Therapeutics

    ... in two models of epilepsy. Shown are data obtained from mice after intraperitoneal dosing with ML297 (60 mg/kg) or sodium valproate ... In (a) are the measured latencies before seizure onset in mice exposed to a lethal electrical shock. Both the antiepileptic positive ...

    cttc_admin - 01/23/2024 - 1:38pm

  3. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    Technology Description Cardiovascular disease remains one of the ...

    cttc_admin - 01/23/2024 - 1:42pm

  4. Startups initiated and grown at Vanderbilt get $4.5M in federal funding, LaunchTN matching grants

    ... Small Business Innovation Research and Small Business Technology Transfer  grants  and matching funds from Launch Tennessee, with the goal of accelerating technology commercialization, innovation and job creation across the state. ...

    sommers - 10/12/2021 - 9:19am

  5. “Ultra-potent” antibody against COVID-19 variants isolated at VUMC

    09/27/2021 A technology developed at Vanderbilt University Medical Center has led to the ... Sept. 15  in the journal  Cell Reports . The technology, called LIBRA-seq, has helped speed up the discovery of antibodies ... describing proof-of-concept development of the LIBRA-seq technology that was published in the journal  Cell  in 2019. “It ...

    sommers - 09/28/2021 - 9:45am

  6. Research Snapshot: Mosquito larvae are surprisingly complex

    ... of commercial products with guidance from the  Center for Technology Transfer and Commercialization . FUNDING This work was ...

    sommers - 09/15/2021 - 4:06pm

  7. Ph.D. to CEO: Entrepreneurial Transformation with the ASPIRE to Innovate Postdoctoral Fellowship Program

    ... ASPIRE Program , and Vanderbilt’s  Center for Technology Transfer and Commercialization will be supporting a biomedical ... of a biomaterial for use in regenerative medicine, a technology developed by Ethan Lippmann, assistant professor of chemical and ...

    sommers - 07/28/2021 - 10:05am

  8. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  9. CTTC commercialized 25 COVID-19-related discoveries, facilitated nine startups during record-setting year

    05/12/2021 The  Center for Technology Transfer and Commercialization  continued to play a pivotal role ... built to reduce back strain. Its patent-pending dual-mode technology turns back assistance on or off, allowing the exosuit to be used in ...

    sommers - 05/26/2021 - 10:39am

  10. Vanderbilt Ranks 35th on the NAI's Top 100 List for U.S. Patents

    ... and Trademark Office, enhancing the visibility of academic technology and innovation, encouraging the disclosure of intellectual property, ...

    sommers - 06/16/2021 - 10:19am